Evaluation of measuring HIV-1 viral load in self-sampled blood.

Evaluation of measuring HIV-1 viral load in self-sampled blood. - Measuring HIV-1 viral load in self-sampled blood.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56653

Enrollment

Registered

2024-03-06

Start date

2024-04-01

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: • adult (aged >= 18 years) living with HIV • speak Dutch or English • provide written informed consent We will include 2 groups of participants. Additional inclusion criteria in the 2 groups are: 1. Prolonged viral suppression group (n=14): • stable on ART • viral load suppressed for more than 2 years • without comorbidities requiring more than one clinic visit per year 2. Persistent low level viremia group (n=30) • receiving ART • known to have low level viremia (200 -400 copies/ mL range).

Exclusion criteria

Exclusion criteria: • No informed consent

Design outcomes

Secondary

Measure	Time frame
• Sample quality (volume and clots) • User friendliness scores • Laboratory logistics	—

Primary

Measure	Time frame
• Agreement in viral loads between: o self-sampled HemoLink and conventional viral load measurement.	—

Countries

Netherlands

Outcome results